Natriumbikarbonat Evolan (Sodium Hydrogen Carbonate)

After oral intake, sodium hydrogen carbonate dissociates into sodium and bicarbonate ions. The bicarbonate reacts with hydrogen ions in the stomach, forming carbonic acid, which quickly breaks down into carbon dioxide and water, raising gastric pH. Systemically, the bicarbonate ion acts as a buffer, increasing the extracellular alkaline reserve and helping to correct low blood pH in metabolic acidosis.

The appropriate dose of Natriumbikarbonat Evolan is determined by the prescribing clinician based on the individual’s condition, age, renal function and other medications. Patients should follow the specific instructions on the prescription label and consult their healthcare provider for any dosage adjustments.

Safety data for sodium hydrogen carbonate in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant, and under the guidance of a qualified healthcare professional. Pregnant or nursing women should discuss use with their doctor.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Sodium hydrogen carbonate offers rapid neutralization of gastric acid and provides systemic alkalinity, which distinguishes it from calcium‑based or aluminum‑based antacids that act locally. Compared with proton‑pump inhibitors, it works faster but for short‑term relief. Choice of therapy depends on the clinical situation and physician recommendation.

The product should be stored at room temperature, below 25 °C, in its original packaging. Protect it from moisture, excessive heat and direct sunlight to maintain stability. Do not store in a refrigerator or freezer unless the label specifically indicates otherwise.

Natriumbikarbonat Evolan is taken orally, typically as a tablet, powder or liquid that is dissolved in water before ingestion, as directed by the prescribing clinician. It should be swallowed with a full glass of water and not chewed unless the formulation specifies otherwise.

The most serious risks include metabolic alkalosis, hypernatremia and severe electrolyte disturbances such as hypokalemia. These conditions can lead to confusion, muscle twitching, hypertension, edema or cardiac arrhythmias and require immediate medical attention. Patients with kidney disease, heart failure or uncontrolled hypertension are at higher risk.

Individuals with known hypersensitivity to sodium bicarbonate, severe renal impairment, uncontrolled hypertension, or those on a sodium‑restricted diet should avoid Natriumbikarbonat Evolan unless a healthcare professional determines it is safe. It is also contraindicated in patients with metabolic alkalosis or those receiving high‑dose sodium‑containing medications without supervision.